A study to evaluate safety and humoral immune response after the third dose of COVID-19 vaccination in a large cohort of multiple sclerosis patients
Latest Information Update: 20 Apr 2022
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 20 Apr 2022 New trial record
- 15 Mar 2022 Results published in the Journal of the Neurological Sciences